| Contradictions in contraindications for drug-drug interactions VS Shah, RJ Weber, MC Nahata Annals of Pharmacotherapy 45 (3), 409-411, 2011 | 19 | 2011 |
| Safety and activity of immune checkpoint inhibitors in people living with HIV and cancer: A real-world report from the cancer therapy using checkpoint inhibitors in people … T El Zarif, AH Nassar, E Adib, BG Fitzgerald, J Huang, TH Mouhieddine, ... Journal of Clinical Oncology 41 (21), 3712-3723, 2023 | 12 | 2023 |
| Single dose versus multiple doses of rituximab for preemptive therapy of Epstein–Barr virus reactivation after hematopoietic cell transplantation T Jain, HE Kosiorek, TE Grys, ST Kung, VS Shah, JA Betcher, JL Slack, ... Leukemia & Lymphoma 60 (1), 110-117, 2019 | 9 | 2019 |
| Treatment with bortezomib-based therapy, followed by autologous stem cell transplantation, improves outcomes in light chain amyloidosis: a retrospective study T Jain, HE Kosiorek, ST Kung, VS Shah, AC Dueck, V Gonzalez-Calle, ... Clinical Lymphoma Myeloma and Leukemia 18 (7), 486-492. e1, 2018 | 9 | 2018 |
| Abemaciclib: the first FDA-approved CDK4/6 inhibitor for the adjuvant treatment of HR+ HER2− early breast cancer F Raheem, H Ofori, L Simpson, V Shah Annals of Pharmacotherapy 56 (11), 1258-1266, 2022 | 7 | 2022 |
| Decreasing drug waste, reducing drug costs, and improving workflow efficiency through the implementation of automated chemotherapy dose rounding rules in the electronic health … V Shah, A Spence, T Bartels, J Betcher, S Soefje American Journal of Health-System Pharmacy 79 (8), 676-682, 2022 | 4 | 2022 |
| Amivantamab-vmjw: a novel treatment for patients with NSCLC harboring EGFR Exon 20 insertion mutation after progression on platinum-based chemotherapy V Shah, A McNatty, L Simpson, H Ofori, F Raheem Biomedicines 11 (3), 950, 2023 | 3 | 2023 |
| Cardiovascular outcomes following bortezomib reinitiation after congestive heart failure diagnosis in multiple myeloma VJ Restrepo, VS Shah, T Jain, JT Larsen, H Narayanasamy, R Arsanjani, ... Journal of the American College of Cardiology 75 (11_Supplement_1), 723-723, 2020 | 3 | 2020 |
| Monoclonal antibody utilization characteristics in patients with multiple myeloma S Ailawadhi, T Sher, AG Azzouqa, Z Meghji, T Jain, P Jani, S Ahmed, ... Anti-cancer drugs 30 (8), 859-865, 2019 | 3 | 2019 |
| Treatment with Bortezomib (Bor) Based Therapy Followed By Autologous Stem Cell Transplantation (SCT) Improves Outcomes in Light Chain Amyloidosis (AL) T Jain, ST Kung, V Shah, AC Dueck, HE Kosiorek, J Mikhael, ... Blood 128 (22), 4629, 2016 | 3 | 2016 |
| Outcomes with pre-emptive rituximab (pre-R) treatment for Epstein-Barr viremia (EBV) after allogeneic hematopoietic stem cell transplantation (HCT) T Jain, ST Kung, H Kosiorek, V Shah, N Khera, J Leis, P Noel, J Palmer, ... Biology of Blood and Marrow Transplantation 23 (3), S279-S280, 2017 | 2 | 2017 |
| Using real-world data to quantify chemotherapy waste at Mayo Clinic. SA Soefje, C Irvine, CE Tucker, VS Shah Journal of Clinical Oncology 40 (28_suppl), 8-8, 2022 | 1 | 2022 |
| Evaluating the Impact of Pharmacist Dual Verification of Anticancer Therapy in the Modern Era DS Stonerock, K Clark, V Shah, CC Irvine, E Draper, SA Soefje Journal of Pharmacy Technology 39 (6), 281-285, 2023 | | 2023 |
| Antibody Drug Conjugates F Raheem, V Shah Breast Cancer Updates, 275-293, 2023 | | 2023 |
| 437 Safety and efficacy of immune checkpoint inhibitors (ICI) in patients living with HIV (PLWH) and metastatic non-small cell lung cancer (NSCLC): a matched cohort study from … T El Zarif, A Nassar, E Adib, B Fitzgerald, J Huang, T Mouhieddine, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | | 2022 |
| Monoclonal Antibody Utilization Characteritics in Patients with Multiple Myeloma S Ailawadhi, AG Azzouqa, Z Meghji, T Jain, N Diehl, SP Gebhardt, V Shah, ... Blood 130, 5440, 2017 | | 2017 |
